TT232, A Novel Signal Transduction Inhibitory Compound in the Therapy of Cancer and Inflammatory Diseases-Reference-Cited by-同舟云学术

TT232, A Novel Signal Transduction Inhibitory Compound in the Therapy of Cancer and Inflammatory Diseases

Author:

SZOKOLÓCZI ORSOLYA¹,SCHWAB RICHÁRD¹,PETÁK ISTVÁN¹²,ÖRFI LÁSZLÓ¹³,PAP ÁKOS¹,EBERLE ALEX N.⁴,SZÜTS TAMÁS⁵,KÉRI1 GYÖRGY¹⁶

Affiliation:

1. Rational Drug Design Laboratories, Cooperative Research Center, Semmelweis University, BudapestHungary

2. 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, BudapestHungary

3. Department of Pharmaceutical Chemistry, Semmelweis University, BudapestHungary

4. Department of Research, University Hospital and University Children' Hospital, BaselSwitzerland

5. Biostatin Research and Development Ltd., BudapestHungary

6. Peptide Biochemistry Research Group, Hungarian Academy of Sciences, and Department of Medical Chemistry, Semmelweis University, BudapestHungary

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

Reference59 articles.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献